$2.2 Infertility Treatment [ART, Insemination, Laparoscopy, Tubal Ligation] Market - Global Forecasts to 2023

Dublin, Nov. 21, 2018 (GLOBE NEWSWIRE) -- The "Infertility Treatment Market by Product, Procedure [ART, Insemination, Laparoscopy, Tubal Ligation], Patient Type, End User - Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%

Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and increasing public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

The female infertility treatment segment is expected to hold the largest market share during the forecast period.

On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

The fertility centers segment is expected to grow at the highest rate during the forecast period.

On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.

The European infertility treatment market is expected to hold the second-largest share during the forecast period.

Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments. Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.2 Market Breakdown and Data Triangulation

3 Executive Summary

4 Premium Insights
4.1 Infertility Treatment Market: Overview
4.2 Geographic Analysis: Market, By Product
4.3 Asia Pacific: Market Share, By Procedure (2018)
4.4 Market, By Patient Type, 2018 vs 2023 (USD Million)
4.5 Market, By End User, 2018 vs 2023 (USD Million)
4.6 Geographical Snapshot of the Global Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Declining Fertility Rate
5.2.1.2 Rising Number of Fertility Clinics Worldwide
5.2.1.3 Technological Advancements
5.2.1.3.1 Advancements in Infertility Treatment Devices
5.2.1.3.1 Increase in the Use of Time-Lapse Technology
5.2.1.4 Increasing Public-Private Investments, Funds, and Grants
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Assisted Reproductive Techniques in Developed Markets
5.2.2.2 Unsupportive Government Regulations
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.1.1 Improving Healthcare Infrastructure
5.2.3.1.2 Increasing Medical Tourism Due to Low Treatment Costs
5.2.3.2 Use of Fertility Treatment Options By Single Parents and Same-Sex Couples
5.2.4 Challenges
5.2.4.1 Concerns Related to Art Procedures
5.2.4.2 Reduced Efficacy Among Older Women

6 Infertility Treatment Market, By Product
6.1 Introduction
6.2 Equipment
6.2.1 Microscopes
6.2.1.1 Growing Technological Advancements in the Field of Microscopy Resulting in the Growing Adoption of Microscopes
6.2.2 Imaging Systems
6.2.2.1 Emergence of Time-Lapse Imaging Systems Driving the Growth of the Infertility Treatment Imaging Systems Market
6.2.3 Sperm Analyzer Systems
6.2.3.1 Automated Sperm Analyzer Systems Permitting Internal and External Quality Control and Better Reproducibility
6.2.4 Ovum Aspiration Pumps
6.2.4.1 Ovum Aspiration Pumps Enable Smooth Collection of Oocytes During Infertility Treatment Procedures
6.2.5 Micromanipulator Systems
6.2.5.1 Micromanipulators are Commonly Used for the Treatment of Male Infertility, Particularly Cases Pertaining to Poor Sperm Quantity/Mobility
6.2.6 Incubators
6.2.6.1 Incubators Play A Vital Role in Embryo Development and Improved Clinical Outcomes
6.2.7 Gas Analyzers
6.2.7.1 Gas Analyzers Contain Multiple Ports Enabling Analysis of Sequential Gas Samples
6.2.8 Laser Systems
6.2.8.1 The Common Applications of Laser Systems Include Treament of Stress Urinary Incontinence and Vaginal Tightening
6.2.9 Cryosystems
6.2.9.1 Demand for Cryosystems is on the Rise as Women are Seeking to Extend Their Childbearing Years
6.3 Media & Consumables
6.3.1 Easy Availability of Culture Media Coupled With the Growing Awareness Among Individuals Driving the Growth of the Media & Consumables Segment
6.4 Accessories
6.4.1 Anti-Vibration Tables are Commonly Used for IVF Treatments to Provide A Smooth Workspace During Procedures

7 Infertility Treatment Market, By Procedure
7.1 Introduction
7.2 Assisted Reproductive Technology
7.2.1 in Vitro Fertilization
7.2.1.1 Intracytoplasmic Morphologically Selected Sperm Injection
7.2.1.1.1 Imsi is Highly Recommended in Patients With A Low Sperm Count and Recurrent Implantation Failure
7.2.1.2 Gamete Donation
7.2.1.2.1 Increase in the Number of Women Registering as Egg Donors is A Key Factor Aiding Market Growth
7.2.2 Intracytoplasmic Sperm Injection
7.2.2.1 Icsi is A Specialized Form of IVF Involving Fertilization Used Commonly in Male Infertility Treatment Procedures
7.2.3 Surrogacy
7.2.3.1 High Success Rates Guaranteed and Achieved With the Help of Surrogacy are Driving Market Growth
7.3 Artificial Insemination
7.3.1 Intrauterine Insemination
7.3.1.1 Limited Risk of Complications During Pregnancy and High Success Rates Driving Market Demand for Iui Procedures
7.3.2 Intracervical Insemination
7.3.2.1 Low Cost of Procedure as Compared to Other AI Procedures Leading to Increased Adoption
7.3.3 Intratubal Insemination
7.3.3.1 Better Chances of Successful Pregnancies Using Iti to Drive the Demand for This Procedure
7.4 Fertility Surgery
7.4.1 Laparoscopy
7.4.1.1 Laparoscopy Allows for the Biopsy of Suspect Growths and Cysts That Hamper Fertility
7.4.2 Hysteroscopy
7.4.2.1 Growing Demand for Minimally Invasive Procedures Driving the Adoption of Hysteroscopy Infertility Treatment Surgeries Globally
7.4.3 Myomectomy
7.4.3.1 Advantages of Myomectomy in Alleviating Problems Caused Due to Fibroids While Preserving Future Fertility to Drive the Demand for This Surgery
7.4.4 Laparotomy
7.4.4.1 Laparotomy is Used in Common Infertility Surgeries That Require Large Exposure to the Reproductive System
7.4.5 Tubal Ligation Reversal
7.4.5.1 Tubal Ligation Reversal is Performed Only in Women Who Still Have A Large Portion of Healthy Fallopian Tube Remaining
7.4.6 Varicocelectomy
7.4.6.1 Adoption of Varicocelectomy is High Among Patients and Results in A High Chance of Improved Fertility With Reduced Complications
7.4.7 Microsurgical Reconstruction
7.4.7.1 Vasovasostomy
7.4.7.1.1 Vasovasostomy is A Reversal Surgery Commonly Used in the Treatment of Infertility in Men
7.4.7.2 Vasoepididymostomy
7.4.7.2.1 Vasoepididymostomy Provides A Higher Pregnancy Rate Than IVF With Icsi
7.5 Other Infertility Treatment Procedures

8 Infertility Treatment Market, By Patient Type
8.1 Introduction
8.2 Female Infertility Treatment
8.2.1 Increasing Female Infertility Rates to Drive the Growth of the Female Infertility Treatment Market
8.3 Male Infertility Treatment
8.3.1 Growing Adoption of Male Infertility Treatment Procedures to Provide Potential Growth Opportunities

9 Infertility Treatment Market, By End User
9.1 Introduction
9.2 Fertility Centers
9.2.1 Growing Number of Infertility Treatment Centers Worldwide Driving Growth of This Segment
9.3 Hospitals and Surgical Clinics
9.3.1 Initiatives Undertaken By Governments to Increase the Number of Hospitals Equipped to Perform Infertility Treatment Procedures Contributing to Market Growth
9.4 Research Institutes
9.4.1 Growing Need for Improving the Clinical Efficacy of Various Infertility Treatment Options Driving Market Growth in Research Institutes
9.5 Cryobanks
9.5.1 Increasing Number of Art Procedures Using Donor Sperm and Donor Eggs for Infertility Treatment Driving the Demand for Cryobanks

10 Infertility Treatment Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 US to Dominate the Infertility Treatment Market in North America
10.2.2 Canada
10.2.2.1 Government Initiatives and Legislations for Same-Sex Marriages to Drive Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Favorable Funding Scenario for IVF Treatments in Germany to Drive the Growth of the Infertility Treatment Market in the Country
10.3.2 UK
10.3.2.1 Increase in the Number of IVF Cycles in the UK Contributing to Market Growth
10.3.3 France
10.3.3.1 The Art Segment Dominated the Infertility Treatment Procedures Market in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Growing Awareness has Served to Boost the Adoption of IVF Procedures in Japan
10.4.2 China
10.4.2.1 Declining Newborn Population and Birth Rate in China to Drive the Demand for Infertility Treatment Procedures in the Country
10.4.3 India
10.4.3.1 Rising Fertility Medical Tourism Offering High-Growth Opportunities for the Infertility Treatment Market in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.1.1 Latin America to Account for the Largest Share of the Rest of the World Infertility Treatment Market
10.5.2 Middle East & Africa
10.5.2.1 Rising Incidence of Male-Factor Infertility to Drive Market Growth During the Forecast Period

11 Competitive Landscape
11.1 Overview
11.2 Infertility Treatment: Market Share Analysis, 2017
11.3 Competitive Scenario

12 Company Profiles

• Cook Group Incorporated
• Esco Micro Pte. Ltd.
• Genea Limited
• Hamilton Throne, Ltd.
• Ihmedical A/S
• Irvine Scientific (A Member of Jx Holdings Group)
• IVFTech Aps
• Kitazato Corporation
• Medgyn Products, Inc.
• Rocket Medical PLC
• Somatex Medical Technologies GmbH
• The Baker Company, Inc.
• The Cooper Companies, Inc.
• Thermo Fisher Scientific
• Vitrolife Ab
• Zeiss Group

For more information about this report visit https://www.researchandmarkets.com/research/wmtms4/2_2_infertility?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Women's Health, Endoscopy, Sexual and Reproductive Health Drugs